Top 5 Penny Stocks to Watch During the Coronavirus Outbreak

penny stocks

Closed borders, Fed rate cuts, and many more major developments in the fight against coronavirus set the markets up for another week of major volatility. The economic toll that the virus is expected to take on countries around the world led to a breakdown in previously safe blue-chip stocks but has presented a great opportunity for investors willing to take a risk on penny stocks.

Penny stocks trade for $5 and under, and they’ve become niche leaders in the coronavirus market, whether they’re actively involved in working on treatment or in a secondary service that has experienced some unexpected boost in recent weeks. Here, we’ll take a look at five of the best performing penny stocks on Monday, March 16.

Top 5 Penny Stocks to Buy Right Now: Antero Resources (NYSE:AR)

AR Stock

Antero Resources is an oil and natural gas company engaged in the exploration, development, and production of natural gas, natural gas liquids (NGLs), and oil properties located in the Appalachian Basin, which produces more natural gas than any OPEC nation. Headquartered in Denver, Colorado, Antero has low cost, liquids-rich drilling operations in two of the premier North American shale plays, the Marcellus and the Utica shales, and is the most integrated NGL and natural gas business in the US due to its market-leading firm transportation portfolio.

Amid a bloodbath on all the major exchanges, AR stock is in the green this morning, and that’s because the perfect storm is brewing for natural gas producers. Supply of natural gas is currently at a seasonally low point, and producers aren’t incentivized to up production because oil prices are at their lowest point since 2016. As oil prices drop, so do gas prices, and they’re currently more economically viable than coal, not to mention better for the environment. As coal users are now expected to transition to gas, there will be a positive supply/demand imbalance next winter.

AR stock is currently trading at $1.27, having sunk to an all-time low of $1.04 on March 11 before a huge spike in trading volume sent the stock up over 20% to see out the week.

Top 5 Penny Stocks to Buy Right Now: Inseego (NASDAQ:INSG)

INSG Stock

Inseego is one of the most pioneering firms in the development of 5G. The California-based company is focused on developing intelligent IoT device-to-cloud solutions that enable high-performance mobile applications for large enterprise verticals, service providers, and small-to-medium businesses around the globe. Inseego has partnered itself with one of the most critical firms to 5G, Qualcomm (NASDAQ:QCOM), which manufacturers the Snapdragon processor, the chip used in the vast majority of Android and iOS mobile devices.

>> 4 Coronavirus Penny Stocks Soaring

Right now, 5G stocks are very much a case of buy the dip, sell the rip. INSG started 2020 by rocketing to a peak valuation of $9.60 in mid-January before the outbreak of the coronavirus dragged it back down below the $7 mark. The stock then climbed back towards that peak in February before buckling as markets entered bear territory last week, dropping over 50% to a low of $4.12 on March 12.

Since then, INSG has recovered around 16% of its value but still looks really undervalued at $4.64. 5G is the future of communication, and the coronavirus outbreak may be a good thing for the demand of 5G internet in major cities as more companies require employees to work from home. In fact, INSG currently has a price target of $8.25 based on six analysts surveyed by TipRanks, which represents an upside of over 70% off its current price.

Top 5 Penny Stocks to Buy Right Now: Valhi Inc (NYSE:VHI)

VHI

Valhi is a holding company that has operations in three segments—chemicals, component products, and waste management. The company’s chemical segment is operated through Kronos Worldwide, Inc., which is a global producer and marketer of titanium dioxide pigment (TiO2). TiO2 is used in the manufacturing of products such as paints, plastics, paper, inks, fibers, foods, pharmaceuticals, and cosmetics. In particular, high-performance grades of TiO2 are finding a growing market in the cosmetics sector, and it is used in almost every brand of toothpaste.

VHI stock has fluctuated between $1.80 and $2.00 for the majority of 2019, before sinking to a low of $0.87 last week amidst the coronavirus-spurred market meltdown. However, the stock has bounced over 20% today on triple the average trading volume as speculators recognize the upside in this pick. For investors in Valhi, the company has three things going for it, the first of which is profitability. Secondly, TiO2 prices have been on the rise for the last two years and are expected to keep growing. Lastly, VHI pays a steady dividend quarter after quarter.

Top 5 Penny Stocks to Buy Right Now: Mustang Bio (NASDAQ:MBIO)

MBIO

Mustang Bio is a clinical-stage biopharmaceutical company focused on developing potential cures for hematologic cancers, solid tumors, and rare genetic diseases, using the latest developments in cell and gene therapies. MBIO’s share price is actually down by 50% since the start of the year, but Cantor Fitzgerald’s Kristen Kluska believes a turnaround is very likely as she sees “no fundamental reason outside of overall stock pressure related to COVID-19,” for the pullback.

>> Top 5 Biggest Penny Stock Gainers to Watch

Mustang has a number of potential therapies in its pipeline, the most promising of which is a treatment for XSCID, commonly known as “bubble boy” disease, a rare genetic condition that results in a severely impaired immune system. Kluska sees great potential in this treatment, judging by a trial concluded last year:

“All patients from the St. Jude trial, presented at ASH 2019 remain alive, up to the age of 39.9 months. We believe this echoes the FDA comments that a drug may be clearly showing effect if survivability trends are observed in even just a few patients… We believe a current market cap of ~$130 million does not reflect the potential of Mustang’s pipeline[…]”

MBIO shares are currently trading for $2.24, up 10% from a recent all-time low of $2.05 at the close of trading last week, suggesting now may be the ideal time to buy the dip.

Top 5 Penny Stocks to Buy Right Now: Heat Biologics (NASDAQ:HTBX)

HTBX

Heat Biologics is a biopharmaceutical company developing immunotherapies designed to activate a patient’s immune system against cancer and other diseases using its proprietary gp96 platform to activate CD8+ “Killer” T-cells. Those projects are on the backburner for the minute after the firm announced that it engaged a government relations firm, PACE LLP, to help it advance collaboration efforts and to secure government funding for a potential coronavirus vaccine.

On Monday, the company said that it had accepted an invite to join the Alliance for Biosecurity, a DC-based coalition of pharmaceutical and biotechnology companies that works to ensure medical countermeasures are available to protect public health and improve the prevention and treatment of severe infectious diseases, including coronavirus.

Heat has been one of the most volatile penny stock movers over the last two weeks. Shares have jumped from lows of under $0.20 to highs of more than $1.20 in just a few short days. At the close of last week, HTBX stock finished out the week at $0.47 but shot up almost 15% on Monday to currently trade at $0.53 following that coronavirus announcement.

The Bottom Line

These are strange days indeed. Not many investors will have experienced an environment so volatile and uncertain to invest in, not even in the midst of the 2008 financial crisis. Suddenly, stable blue-chip investments are no longer a source of risk-free, steady gains, which means some smaller penny stocks may now offer ample opportunity for speculators to capitalize on potentially undervalued gems.

>> Read More Penny Stocks News

Featured Image: DepositPhotos © designer491

Please See Disclaimer

If You Liked This Article Click To Share


Risks and Disclosure:

Information provided in this correspondence is intended solely for informational purposes and is obtained from sources believed to be reliable. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained on this website is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions made or suggested and the actual results.

All statements and opinions expressed are the opinions of the author and not of Microsmallcap.com or its officers. The author is wholly responsible for the validity of all statements. Microsmallcap.com was not involved in any aspect of the article preparation. The author was not paid by Market Jar Media Inc for this article. The author did not pay Microsmallcap.com to publish or syndicate this article.

This article does not constitute as investment advice. Each reader is encouraged to consult with his or her individual financial advisor; any and all actions taken by a reader as a result of the information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Microsmallcap.com's terms of use and full legal disclaimer. This article is in no way a solicitation for investment. Microsmallcap.com does not render general or specific investment advice. Any information on Microsmallcap.com should not be considered a recommendation to buy or sell any security. Microsmallcap.com does not endorse or recommend the business, products, services or securities of any company mentioned on Microsmallcap.com.

Futures, stocks and options trading involves substantial risk of loss and is not suitable for every investor. The valuation of futures, stocks, and options may fluctuate, and, as a result, clients may lose more than their original investment and possibly their entire investment. Any content on this website should not be relied upon as advice or construed as providing recommendations of any kind. It is your responsibility to confirm and decide which trades to make. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

Please see our full disclaimer here for additional details before making any investment decisions.